Key Details of the Demand Notice
Authority: National Pharmaceutical Pricing Authority (NPPA)
Date of Receipt: July 29, 2026
Nature of Action: Demand notice for alleged overcharging under the Drugs (Prices Control) Order, 2013 (DPCO, 2013)
Product Involved: Symbicort Turbuhaler (Inhaler)
Period of Alleged Violation: May 2016 to November 2025
Demand Amount: ₹1,48,65,83,590 (One Hundred Forty Eight Crore Sixty Five Lakh Eighty Three Thousand Five Hundred Ninety Rupees)
Interest Calculation: Interest calculated up to August 20, 2026
Payment Deadline: Within 30 days from receipt of the notice (by approximately August 28, 2026)
Background and Context
The company had previously received a show cause notice dated September 11, 2025, followed by communication dated September 12, 2025. The current demand notice received on July 29, 2026, represents the culmination of that process.
Company Response and Status
The company is currently evaluating the demand notice and considering appropriate legal actions. No further details about specific legal strategies or timeline for response are provided in the disclosure.
Financial Impact
The disclosure explicitly quantifies the financial impact at ₹1,48,65,83,590 inclusive of interest calculated up to August 20, 2026. This amount represents the total demand payable within 30 days of receipt of the notice.